Paul Stockdale
Patrimonio netto: 8 527 $ in data 30/06/2026
Patrimonio netto: 8 527 $ in data 30/06/2026
Paul Stockdale currently works at Oxford BioDynamics Plc, as Chief Financial Officer & Executive Director.
Mr. Stockdale also formerly worked at e-Therapeutics Plc, as Financial Controller from 2012 to 2017 and Deloitte & Touche LLP UK, as Senior Manager from 1996 to 2004.
Mr. Stockdale received his graduate degree from the University of Cambridge.
| Società | Data | Numero di azioni | Valutazione | Data di valutazione |
|---|---|---|---|---|
| 10/11/2025 | 6.411.252 ( 0,15% ) | 8 527 $ | 30/06/2026 |
| Società | Posizione | Inizio |
|---|---|---|
| OXFORD BIODYNAMICS PLC | Direttore Finanziario/CFO | 15/09/2017 |
| Società | Posizione | Fine |
|---|---|---|
| E-THERAPEUTICS PLC | Comptroller/Controller/Auditor | 01/09/2017 |
Deloitte & Touche LLP UK
Deloitte & Touche LLP UK Miscellaneous Commercial ServicesCommercial Services Provides financial advisory and accounting services | Corporate Officer/Principal | 01/01/2004 |
Attive
Inattive
Società nel listino
Aziende private
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
| Aziende private | 4 |
|---|---|
e-Therapeutics Plc
e-Therapeutics Plc BiotechnologyHealth Technology Discovers and develops drugs | Health Technology |
University of Cambridge
University of Cambridge Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Deloitte & Touche LLP UK
Deloitte & Touche LLP UK Miscellaneous Commercial ServicesCommercial Services Provides financial advisory and accounting services | Commercial Services |
Oxford BioDynamics Plc
Oxford BioDynamics Plc BiotechnologyHealth Technology Discovers and develops novel biomarkers | Health Technology |
Seleziona la tua edizione
Tutte le informazioni finanziarie adattate in base al livello nazionale